Mast Therapeutics Sees Large Decrease in Short Interest (MSTX)
Mast Therapeutics (NYSE:MSTX) saw a large decrease in short interest in August. As of August 15th, there was short interest totalling 7,852,415 shares, a decrease of 5.8% from the July 31st total of 8,334,862 shares, AR Network reports. Approximately 6.8% of the company’s stock are short sold. Based on an average daily volume of 570,359 shares, the short-interest ratio is currently 13.8 days.
Shares of Mast Therapeutics (NYSE:MSTX) opened at 0.61 on Wednesday. Mast Therapeutics has a one year low of $0.40 and a one year high of $1.10. The stock’s 50-day moving average is $0.60 and its 200-day moving average is $0.65. The company’s market cap is $74.2 million.
Mast Therapeutics, Inc, formerly ADVENTRX Pharmaceuticals, Inc, is a development-stage company biopharmaceutical company focused on developing product candidates.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.